Clinical Trial Update: Influence of Organic Anion Transporting Polypeptide1B1(OATP1B1) Genotype on Rosuvastatin PK, PD and Lipid Profiles [Phase 4]

View source ↗

Summary

Phase 4 trial update examining how OATP1B1 genotype influences rosuvastatin pharmacokinetics, pharmacodynamics, and lipid responses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Hypercholesterolemia
• Hypercholesterolemia
• Hyperlipidemia

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Organic Anion Transporting Polypeptide1B1 (OATP1B1), Rosuvastatin | Phase 4 | Status: COMPLETED